Semax 10 mg is a synthetic, high-purity (99%+), lyophilised research compound supplied for laboratory research only. It is a simplified analogue of a fragment of adrenocorticotropic hormone (ACTH 4-10) with a stabilising Pro-Gly-Pro sequence, and is studied in neuroscience research.
Key Details
- Research areas: Neuroplasticity, BDNF expression, neuroprotection and stress-response pathways in cell and animal models.
- Mechanism of interest: Studied for effects on Brain-Derived Neurotrophic Factor (BDNF) and modulation of neurotransmitter systems.
- Format: White lyophilised (freeze-dried) powder in a sealed vial, requiring reconstitution for experimental use.
Research Background
Semax was originally developed in Russia and is studied in preclinical models of neuronal injury and neurogenesis. Findings from these studies should not be extrapolated to humans. It is a research compound and is not approved for therapeutic use in Australia.
Storage
Store the lyophilised powder in a cool, dark place, or refrigerate at 2°C to 8°C. Once reconstituted with bacteriostatic water, keep chilled and use within the recommended laboratory timeframe.
For laboratory and research purposes only. Not for human consumption, medical use, or veterinary use.
